文献速递脑血管病神经重症与神经感染

COVID-19患者的神经与神经影像学发现:回顾性多中心研究

Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.
PubMed 文献 · Neurology · 2020-07-17

该回顾性多中心研究纳入64例伴神经系统表现且接受脑MRI的COVID-19确诊患者,56%脑MRI异常,最常见为缺血性卒中(27%)、软脑膜强化(17%)和脑炎(13%);意识模糊最常见(53%)。脑炎患者更年轻,软脑膜强化者激越更常见;脑脊液无病毒但存在炎症迹象,提示免疫或炎症机制。

要点

  • COVID-19伴神经症状患者中56%脑MRI异常,缺血性卒中占27%。
  • 意识模糊是最常见神经表现(53%),其次为意识受损(39%)。
  • 脑炎患者更年轻,软脑膜强化者激越更常见。

核心结论

  • COVID-19患者可出现广泛神经系统症状,并可伴缺血性卒中或脑炎等严重并发症。
  • 脑膜脑炎受累即使不能排除病毒直接作用,脑脊液无病毒而脑脊液和神经影像有炎症迹象,提示免疫或炎症过程。

研究设计与样本

  • 回顾性多中心研究,纳入11家医院64例伴神经系统表现且接受脑MRI的COVID-19确诊患者。
  • 队列包括43例男性(67%)和21例女性(33%),中位年龄66岁(范围20-92岁)。

主要发现

  • 36例(56%)脑MRI异常,可能与非严重急性呼吸综合征冠状病毒相关。
  • 最常见的神经影像学发现为缺血性卒中(27%)、软脑膜强化(17%)和脑炎(13%)。
  • 最常见的神经系统表现为意识模糊(53%),其次为意识受损(39%)、皮质脊髓束受累临床体征(31%)、激越(31%)和头痛(16%)。
  • 缺血性卒中患者较其他脑影像异常患者更少发生急性呼吸窘迫综合征(p = 0.006),更常出现皮质脊髓束体征(p = 0.02)。
  • 脑炎患者更年轻(p = 0.007),软脑膜强化患者激越更常见(p = 0.009)。

临床怎么用

  • 对伴神经系统表现的COVID-19患者应警惕缺血性卒中、脑炎等严重并发症,及时行脑MRI评估。
  • 脑膜脑炎受累时脑脊液无病毒但存在炎症迹象,提示免疫或炎症机制,支持免疫调节治疗考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe neuroimaging findings and to report the epidemiologic and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) with neurologic manifestations. METHODS: In this retrospective multicenter study (11 hospitals), we included 64 patients with confirmed COVID-19 with neurologic manifestations who underwent a brain MRI. RESULTS: The cohort included 43 men (67%) and 21 women (33%); their median age was 66 (range 20-92) years. Thirty-six (56%) brain MRIs were considered abnormal, possibly related to severe acute respiratory syndrome coronavirus. Ischemic strokes (27%), leptomeningeal enhancement (17%), and encephalitis (13%) were the most frequent neuroimaging findings. Confusion (53%) was the most common neurologic manifestation, followed by impaired consciousness (39%), presence of clinical signs of corticospinal tract involvement (31%), agitation (31%), and headache (16%). The profile of patients experiencing ischemic stroke was different from that of other patients with abnormal brain imaging: the former less frequently had acute respiratory distress syndrome (p = 0.006) and more frequently had corticospinal tract signs (p = 0.02). Patients with encephalitis were younger (p = 0.007), whereas agitation was more frequent for patients with leptomeningeal enhancement (p = 0.009). CONCLUSIONS: Patients with COVID-19 may develop a wide range of neurologic symptoms, which can be associated with severe and fatal complications such as ischemic stroke or encephalitis. In terms of meningoencephalitis involvement, even if a direct effect of the virus cannot be excluded, the pathophysiology seems to involve an immune or inflammatory process given the presence of signs of inflammation in both CSF and neuroimaging but the lack of virus in CSF. CLINICALTRIALSGOV IDENTIFIER: NCT04368390.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kremer S, Lersy F, Anheim M, et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020. PMID: 32680942. doi:10.1212/WNL.0000000000010112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。